| Day one: Tuesday 29th January 2008 |
| 08:30 |
|
Registration |
| 09:00 |
Neil Mahoney
CEO
GLOBAL BUSINESS MANAGEMENT CONCEPTS |
Opening remarks from the Chair |
| STRATEGIC IMPACT OF CI ON BUSINESS DEVELOPMENT |
| 09:10 |
Branimir Brankov
Senior Director
Global Competitive Intelligence
MERCK&CO |
The stategic impact of Competitive Intelligence (CI) on Business developement
- How competitive intelligence impacts and contributes to the licensing process.
- Focusing on how companies can create and maximise competitive intelligence to help them make better and faster decisions during the licensing and M&A process
- Looking at the resources needed to undertake this effort
|
| 09:50 |
Jodie Peake
Project Manager - Healthcare Practice
FULD & COMPANY |
Driving growth through intellectual property acquisition: applying CI to pharmaceutical licensing
- Establish a framework for identifying in-licencing opportunities
- Learn the benefits of using CI to promote innovation through acquisition
- How to apply CI techniques to confirm the most valuable acquisition targets
|
| 10:30 |
|
Morning refreshments |
| 11:00 |
Robin Kirkby
Director of Strategic Intelligence
NYCOMED |
Ensuring that the intelligence capability survives when the company is acquired
- Practical advice to ensure the survival of the intelligence capability
- Adding value to the acquisition and integration process
- Creating new customers and new deliverables
- Communicating the successes
- Lessons learnt - do's and don'ts
|
| CI AND ASSESSING THE COMPETITIVE GENERIC MARKET |
| 11:40 |
Neil Mahoney
CEO
GLOBAL BUSINESS MANAGEMENT CONCEPTS |
Examining generic developments in the US and EU
- A primer on generic industry market dynamics
- Roche-Bolar and Hatch-Waxman review
- The generic industry portfolio management process
- EU generic industry dynamics
|
| 12:20 |
Rafaat Rahmani
Founder and President
LIFESCIENCE DYNAMICS |
Generic defence for a big pharma company by reducing or neutralising supply-side risk
- Assessment of the likely generic sources and levels of competition to the product in the coming years
- Measuring a supply-side strategy on how to best counteract competition threat
- Undertaking secondary and primary CI to assess the likely market attractiveness for generic competition
- Developing a proprietary rating system based on generic capability and intent to supply
|
| 13:00 |
|
Lunch |
| ONGOING IMPROVEMENT OF THE CI/BI PROCESSES AND TOOLS |
| 14:10 |
Corina Turnes
Director - European Practice
PENNSIDE PARTNERS GMBH |
The ins and outs of CI in Pharma: similarities, differences and resource prerequisites
- Overview of clinical intelligence tools and resources in Pharma
- Main similarities and differences between tools and resources
- Case study example
- Resource prerequisites for clinical intelligence in Pharma
- Key learning for your CI practice
|
| 14:50 |
Robert Franc
Director of Competitive Intelligence
CENTOCOR |
Developing the organisational and technical infrastructure to support the CI function
- Using performance management to elevate the benefits of business intelligence in your organisation
- Common problems and experiences in managing a business intelligence function
- Creating CI objectives: budget, organisational structures and pricing issues
- Best practice methods for managing processes and CI implementation
|
| 15:30 |
|
Afternoon refreshments |
| 16:00 |
Coralie Hughes
Manager,
Global Competitive Intelligence
ELI LILLY |
Competitor response modelling: a risk reduction tool
- Tools and techniques for competitor analysis
- From the external to the internal drivers
- War gaming made practical
- Natural partnership of market research and CI
|
| 16:40 |
Richard Withers
Managing Partner
COMPELLING EDGE |
War Gaming: a CI analysis tool for anticipating competitor actions
- Game theory and business – testing beliefs and assumptions about the pharma business environment
- Applying game theory suggestions to CI
- Identifying when to run strategy games
- The benefits of game theory on decision making and business development
|
| 17:20 |
|
Closing remarks from the Chair and end of day one |
|
|
 |
| |
|
|
| Day two: Wednesday 30th January 2008 |
| 08:30 |
|
Registration |
| 09:00 |
Neil Mahoney
CEO
GLOBAL BUSINESS MANAGEMENT CONCEPTS |
Opening remarks from the Chair |
| 09:10 |
ROUNDTABLE MORNING |
Delegates will be able to attend three one-hour roundtable discussion groups from a selection of key topics. Each session will be chaired by an industry expert who will facilitate an exchange of opinions, essential experiences and learning related to an aspect of Competitive Intelligence. |
| |
Robin Kirkby
Director of Strategic Intelligence
NYCOMED |
Managing the CI functions during merger and acquisition
|
| |
Jonas Pedersen
Managing Partner
COMPELLING EDGE |
War game scenarios –using the outcomes in the real world
|
| |
Robert Franc
Director of Competitive Intelligence
CENTOCOR |
Building and positioning a CI team within the enterprise
|
| |
Neil Mahoney
CEO
GLOBAL BUSINESS MANAGEMENT CONCEPTS |
Examining generic developments in the US and EU
|
| |
Branimir Brankov
Senior Director
Global Competitive Intelligence
MERCK&CO |
How to increase CI productivity and effectiveness
|
| |
Rafaat Rahmani
Founder and President
LIFESCIENCE DYNAMICS |
Communicating intelligence throughout the company
|
| 12:20 |
|
Lunch |
| USING CI TO GAIN COMPETITIVE ADVANTAGE |
| 13:50 |
Kees Deijl
Associate Director Competitive Intelligence
ORGANON |
Bridging R&D and the role of the CI
- The need for change
- Establishing proof-of-concept based research
- Implementing translational sciences early in the process
- Optimising the role of CI in the process
|
| 14: 30 |
Jorg Klug
Business Intelligence Manager EMEA
JANSSEN-CILAG |
The CI process in pharmaceutical strategic marketing
- Identifying critical issues: Which competitive events could seriously hurt the forecast? Which can be addressed by CI?
- Managing the key stakeholders: Who in the organisation holds specific information? Who ought to know what and when?
- Implementing relevant CI tools: When do competitive workshops, KIT/ KIQ tracking and competitor profiling add value?
- CI in pharmaceutical strategic marketing in practice: short case studies of perceived CI successes and failures
|
| 15:10 |
Mohammad Sikder
Business Intelligence Manager
SANOFI AVENTIS |
Using competitor data to drive strategy and market success
- Competitor profiling – knowing who to monitor and how to communicate with them
- Legal issues concerning business strategy and CI
- Keeping track of industry news and studies
- Creating an effective strategy to ensure market success
|
| 15:50 |
|
Closing remarks from the Chair and Champagne prize draw |
| 16:00 |
|
End of the conference and farewell tea and coffee |
| |
|
 |